Several in vitro and in vivo studies have clearly shown that the Mnk-eIF4E axis promotes BC transformation and tumor progression [12,13,14,26,28], findings that are also supported by clinical data [7,15,22,28,57,58]. This evidence concerns the gene EIF4E and neoplasm.